Catalio Capital Management Revenue and Competitors
Estimated Revenue & Valuation
- Catalio Capital Management's estimated annual revenue is currently $7.6M per year.
- Catalio Capital Management's estimated revenue per employee is $181,600
Employee Data
- Catalio Capital Management has 42 Employees.
- Catalio Capital Management grew their employee count by 0% last year.
Catalio Capital Management's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP | Reveal Email/Phone |
2 | VP – North America | Reveal Email/Phone |
3 | General Counsel | Reveal Email/Phone |
4 | Head Finance | Reveal Email/Phone |
5 | Head Research | Reveal Email/Phone |
6 | Head European & Middle Eastern Institutional Sales | Reveal Email/Phone |
7 | Head Investor Services | Reveal Email/Phone |
8 | General Counsel | Reveal Email/Phone |
9 | VP -North America | Reveal Email/Phone |
10 | Partner, Portfolio Manager | Reveal Email/Phone |
Catalio Capital Management Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $7.3M | 40 | 8% | N/A | N/A |
#2 | $38.8M | 159 | 11% | N/A | N/A |
#3 | $58.2M | 233 | 5% | N/A | N/A |
#4 | $37.1M | 152 | -7% | N/A | N/A |
#5 | $3.5M | 22 | 0% | N/A | N/A |
#6 | $6.5M | 36 | -3% | N/A | N/A |
#7 | $17.9M | 79 | 8% | N/A | N/A |
#8 | $282.4M | 870 | 0% | N/A | N/A |
#9 | $6M | 20 | 5% | $73M | N/A |
#10 | $46.2M | 185 | 2% | N/A | N/A |
What Is Catalio Capital Management?
Catalio Capital Management was created by George Petrocheilos and Dr. Jacob Vogelstein to invest in breakthrough biomedical technology companies created or referred by Catalio Capital Management, an elite group of world-renowned, serial scientist-entrepreneurs.
keywords:N/A
N/A
Total Funding
42
Number of Employees
$7.6M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Catalio Capital Management News
... today announced an $80 million Series B financing round led by Catalio Capital Management (Catalio), established a Deep Mutational...
... medicines for complex diseases, has raised $80 million in a Series B financing round led by Catalio Capital Management (Catalio).
It's clearly convinced Catalio Capital Management, a firm with five successful IPOs to its name since it was founded in 2020. Catalio led Octant's series B...
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $8.4M | 42 | 8% | N/A |
#2 | $3.4M | 42 | 0% | N/A |
#3 | $4.9M | 42 | 0% | N/A |
#4 | $8.6M | 42 | -11% | $15M |
#5 | $7.5M | 42 | 0% | N/A |